Page History
...
If your trial is Complete, follow the instructions in Registering New Complete Trials.
- Cancer Center trials must meet the following criteria to be eligible for registration:
- Trials must have been active as of January 1, 2009 or any time thereafter.
- Submitting organization is the Lead Organization or the Coordinating Center.
- CTEP or DCP PIO-managed trials must meet the following criteria to be eligible for registration:
- If NCI-managed, trials must have been active as of January 1, 2009 or any time thereafter.
If NCI-sponsored, trials must have been still open (not yet Completed) as of December 26, 2007 or opened anytime thereafter.
Note Cancer Centers do not register PIO-managed trials or NCI-CCR trials. PIO-managed trials are submitted to CTRP directly by CTEP and DCP. NCI-CCR trials are managed in ClinicalTrials.gov by CCR.
...
- If your organization is not an NCI-designated Cancer Center organization, NIH institute, or pharmaceutical company, you will need to import the trial directly from ClinicalTrials.gov. Instructions for For instructions on this process can be found under , refer to Registering Abbreviated (Industrial and Other) Trials.
Info |
---|
The system assigns the trial you import from ClinicalTrials.gov the Data Table 4 Category (funding source) Industrial/Other. (For information, refer to CTRP Trial Categories, Study Sources.) To specify whether the trial is Industrial, or to specify if an Other trial is National or Externally Peer-Reviewed, contact the CTRO for assistance at ncictro@mail.nih.gov. For funding source definitions, refer to https://cancercenters.cancer.gov/GrantsFunding/eData#dt4. |
- If your organization is the Lead Organization on a trial, and your organization is an NCI-designated Cancer Center organization, do not import the trial from ClinicalTrials.gov. Instead, submit the trial to CTRP as a Complete trial, as described in . For instructions, refer to Registering New Complete Trials.
- If your organization is the Lead Organization for any trial on anything other than an NCI-designated Cancer Center organization, NIH institute, or pharmaceutical company trial, the CTRO contacts the Center and further categorizes the trial as Other/National or Other/Externally Peer-Reviewed based on whether your trial is conducted under an NIH grant, as follows:
- If your trial is conducted under an NCI grant, the CTRO categorizes it as a Consortia trial.
- If your trial is not conducted under an NCI grant, the CTRO categorizes it as follows:
- Other/National, for trials sponsored by an NIH institute
- Other/Externally Peer-Reviewed, for trials managed by a hospital or a center other than one designated by the NCI
...